Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.
Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA, Guerra M, Guo W, Xu X.
Oncogene. 2012 Jan 30. doi: 10.1038/onc.2011.656. [Epub ahead of print]
Related citations
IL-3 is a novel target to interfere with tumor vasculature.
Dentelli P, Rosso A, Olgasi C, Camussi G, Brizzi MF.
Oncogene. 2011 Dec 15;30(50):4930-40. doi: 10.1038/onc.2011.204. Epub 2011 Jun 6.
p53 promotes cellular survival in a context-dependent manner by directly inducing the expression of haeme-oxygenase-1.
Nam SY, Sabapathy K.
Oncogene. 2011 Nov 3;30(44):4476-86. doi: 10.1038/onc.2011.150. Epub 2011 May 9.
Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice.
Nitzki F, Zibat A, Frommhold A, Schneider A, Schulz-Schaeffer W, Braun T, Hahn H.
Oncogene. 2011 Oct 27;30(43):4428-36. doi: 10.1038/onc.2011.157. Epub 2011 May 23.
Girdin maintains the stemness of glioblastoma stem cells.
Natsume A, Kato T, Kinjo S, Enomoto A, Toda H, Shimato S, Ohka F, Motomura K, Kondo Y, Miyata T, Takahashi M, Wakabayashi T.
Oncogene. 2012 May 31;31(22):2715-24. doi: 10.1038/onc.2011.466. Epub 2011 Oct 24.
Lgr5 and Lgr6 as markers to study adult stem cell roles in self-renewal and cancer.
Leushacke M, Barker N.
Oncogene. 2011 Oct 17. doi: 10.1038/onc.2011.479. [Epub ahead of print]
Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.
Cao L, Shao M, Schilder J, Guise T, Mohammad KS, Matei D.
Oncogene. 2012 May 17;31(20):2521-34. doi: 10.1038/onc.2011.429. Epub 2011 Oct 3.
The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.
Buijs JT, van der Horst G, van den Hoogen C, Cheung H, de Rooij B, Kroon J, Petersen M, van Overveld PG, Pelger RC, van der Pluijm G.
Oncogene. 2012 Apr 26;31(17):2164-74. doi: 10.1038/onc.2011.400. Epub 2011 Sep 26.
Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2.
Garcia CB, Shaffer CM, Alfaro MP, Smith AL, Sun J, Zhao Z, Young PP, Vansaun MN, Eid JE.
Oncogene. 2012 May 3;31(18):2323-34. doi: 10.1038/onc.2011.418. Epub 2011 Sep 26.
Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
Paranjape AN, Mandal T, Mukherjee G, Kumar MV, Sengupta K, Rangarajan A.
Oncogene. 2012 Apr 12;31(15):1896-909. doi: 10.1038/onc.2011.378. Epub 2011 Aug 29.
Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells.
Zhang Y, Wang C.
Oncogene. 2011 Aug 11;30(32):3549-62. doi: 10.1038/onc.2011.69. Epub 2011 Mar 21.
Sox2 expression in breast tumours and activation in breast cancer stem cells.
Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R, Martin AG.
Oncogene. 2012 Mar 15;31(11):1354-65. doi: 10.1038/onc.2011.338. Epub 2011 Aug 8.
Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
Jiang J, Zhang Y, Chuai S, Wang Z, Zheng D, Xu F, Zhang Y, Li C, Liang Y, Chen Z.
Oncogene. 2012 Feb 9;31(6):671-82. doi: 10.1038/onc.2011.282. Epub 2011 Jul 11.
Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
Farabaugh SM, Micalizzi DS, Jedlicka P, Zhao R, Ford HL.
Oncogene. 2012 Feb 2;31(5):552-62. doi: 10.1038/onc.2011.259. Epub 2011 Jun 27.
Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.
Bourguignon LY, Earle C, Wong G, Spevak CC, Krueger K.
Oncogene. 2012 Jan 12;31(2):149-60. doi: 10.1038/onc.2011.222. Epub 2011 Jun 20.
Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.
Floor S, van Staveren WC, Larsimont D, Dumont JE, Maenhaut C.
Oncogene. 2011 Nov 17;30(46):4609-21. doi: 10.1038/onc.2011.184. Epub 2011 Jun 6. Review.
Loss of the Birt-Hogg-Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcription.
Cash TP, Gruber JJ, Hartman TR, Henske EP, Simon MC.
Oncogene. 2011 Jun 2;30(22):2534-46. doi: 10.1038/onc.2010.628. Epub 2011 Jan 24.
Evidence for the transmission of neoplastic properties from transformed to normal human stem cells.
Werbowetski-Ogilvie TE, Schnerch A, Rampalli S, Mills CE, Lee JB, Hong SH, Levadoux-Martin M, Bhatia M.
Oncogene. 2011 Nov 17;30(46):4632-44. doi: 10.1038/onc.2011.175. Epub 2011 May 30.
Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang Z, Yang CJ, Yuan L, Ouyang G.
Oncogene. 2011 Nov 24;30(47):4707-20. doi: 10.1038/onc.2011.181. Epub 2011 May 23.
Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.
Bu W, Chen J, Morrison GD, Huang S, Creighton CJ, Huang J, Chamness GC, Hilsenbeck SG, Roop DR, Leavitt AD, Li Y.
Oncogene. 2011 Oct 27;30(43):4399-409. doi: 10.1038/onc.2011.147. Epub 2011 May 2.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on